Discontinuation of hypnotics during cognitive behavioural therapy for insomnia
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18801160
PubMed Central
PMC2562375
DOI
10.1186/1471-244x-8-80
PII: 1471-244X-8-80
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- farmakoterapie statistika a číselné údaje MeSH
- hypnotika a sedativa terapeutické užití MeSH
- kognitivně behaviorální terapie metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- nenasazení léčby statistika a číselné údaje MeSH
- polysomnografie MeSH
- poruchy iniciace a udržování spánku diagnóza farmakoterapie terapie MeSH
- senioři MeSH
- spánek REM fyziologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- hypnotika a sedativa MeSH
BACKGROUND: In practical sleep medicine, therapists face the question of whether or not to discontinue the ongoing use of hypnotics in patients, as well as the possible effects of discontinuation. The aim of this study was to evaluate the effects of discontinuing third-generation hypnotics on the results of cognitive-behavioural therapy (CBT) for primary insomnia in patients after long-term abuse. METHODS: Twenty-eight outpatients were treated by CBT for 8 weeks. The treatment outcome was estimated by means of differences among subjective clinical scales and polysomnography variables assessed before and after the treatment period. The therapeutic effect in a subgroup of 15 patients who had previously received hypnotics and were successively withdrawn during weeks 2-6 was compared to the effect achieved in patients who had not used hypnotics before CBT. RESULTS: There were no significant differences in baseline subjective and objective sleep characteristics between the hypnotic abusers and non-abusers. According to clinical scales and most polysomnographic measures, CBT was highly effective in both groups of subjects; it produced the greatest changes in total sleep time, REM sleep and sleep efficiency. Unexpectedly, discontinuation of hypnotics, as a factor in the analysis, was followed by an additional improvement of sleep efficiency and wake after sleep onset parameters. CONCLUSION: Our study confirmed the efficacy of CBT in both hypnotic-abusing and non-abusing patients with chronic insomnia. The results of this study suggest that tapered withdrawal of third-generation hypnotics during CBT therapy for chronic insomnia could be associated with improvement rather than worsening of sleep continuity.
Zobrazit více v PubMed
Monti JM. Effect of zolpidem on sleep in insoniac patients. Eur J Clin Pharmacol. 1989;36:461–466. doi: 10.1007/BF00558070. PubMed DOI
Declerck A, Smits M. Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia? J Int Med Res. 1999;27:253–263. PubMed
Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. Eur Arch Psychiatry Clin Neurosci. 2001;251:117–123. doi: 10.1007/s004060170045. PubMed DOI
Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004) Sleep. 2006;29:1398–1414. PubMed
Mendelson WB. Combining pharmacologic and nonpharmacologic therapies for insomnia. J Clin Psychiatry. 2007;68:19–23. PubMed
Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, NIlesen GH, Nordhus IH. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adultrs: a randomized controlled trial. JAMA. 2006;295:2851–2858. doi: 10.1001/jama.295.24.2851. PubMed DOI
Morin CM, Bastien CH, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive-behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry. 2004;161:332–342. doi: 10.1176/appi.ajp.161.2.332. PubMed DOI
Belleville G, Guay C, Guay B, Morin CM. Hypnotik taper with or without self-help of insomnia: a randomized clinical trial. J Consult Clin Psychol. 2007;75:325–335. doi: 10.1037/0022-006X.75.2.325. PubMed DOI
Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164:1888–1896. doi: 10.1001/archinte.164.17.1888. PubMed DOI
Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technol Assess. 2004;8:iii-iv, 1–68. PubMed
World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO; 1993.
Morin CM, Espie CA. Insomnia: a clinical guide to assessment and treatment. New York: KluwerAcademic/Plenum Publishers; 2003.
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–545. PubMed
Beck AT, Rial WY, Rickels K. Short form of depression inventory: cross-validation. Psychol Rep. 1974;34:1184–1186. PubMed
Beck AT, Steer R, Garbin M. Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100. doi: 10.1016/0272-7358(88)90050-5. DOI
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. doi: 10.1037/0022-006X.56.6.893. PubMed DOI
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55. PubMed
Guy W. ECDEU Assessment Manual for Psychopharmacology, revised 1976. Rockville, MD: National Institutes of Mental Health; 1976. Clinical Global Impression.
Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: U.S. Government Printing Office; 1968. PubMed
Jacobs GD, Benson H, Friedman R. Perceived benefits in a behavioral medicine insomnia program: a clinical report. Am J Med. 1996;100:212–216. doi: 10.1016/S0002-9343(97)89461-2. PubMed DOI
Jacobs GD, Benson H, Friedman R. Home-based central nervous system assessment of a multifactor behavioral intervention for chronic sleep-onset insomnia. Behav Ther. 1993;24:159–174. doi: 10.1016/S0005-7894(05)80261-8. DOI
Means MK, Lichstein KL, Epperson MT, Johnson CT. Relaxation therapy for insomnia: nighttime and day time effects. Behav Res Ther. 2000;38:665–678. doi: 10.1016/S0005-7967(99)00091-1. PubMed DOI
Morin CM. Combined therapeutics for insomnia: should our first approach be behavioral or pharmacological? Sleep Med. 2006;1:S15–19. doi: 10.1016/j.sleep.2006.03.005. PubMed DOI
Matousek M, Cervena K, Zavesicka L, Brunovsky M. Subjective and objective evaluation of alertness and sleep quality in depressed patients. BMC Psychiatry. 2004;26:14. doi: 10.1186/1471-244X-4-14. PubMed DOI PMC